Latest Insider Transactions at Option Care Health, Inc. (OPCH)
This section provides a real-time view of insider transactions for Option Care Health, Inc. (OPCH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Option Care Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Option Care Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2025
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
10,713
-11.94%
|
$353,529
$33.09 P/Share
|
|
May 19
2025
|
Collin Smyser GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
11,196
+5.69%
|
-
|
|
May 14
2025
|
Barbara W. Bodem Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,034
+29.4%
|
-
|
|
May 14
2025
|
Timothy P Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,415
+13.33%
|
$126,225
$15.9 P/Share
|
|
May 14
2025
|
R Carter Pate Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,034
+10.9%
|
-
|
|
May 14
2025
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,056
+1.9%
|
$195,840
$15.9 P/Share
|
|
May 14
2025
|
David W Golding Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,415
+3.57%
|
$126,225
$15.9 P/Share
|
|
May 14
2025
|
Natasha Deckmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,661
+10.85%
|
$84,915
$15.9 P/Share
|
|
May 14
2025
|
Elizabeth D Bierbower Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,034
+17.41%
|
-
|
|
May 14
2025
|
Elizabeth Quadros Betten Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,034
+16.03%
|
-
|
|
May 14
2025
|
Eric Brandt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,034
+32.7%
|
-
|
|
May 14
2025
|
Norman L. Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,034
+29.4%
|
-
|
|
Apr 22
2025
|
Femi Adewunmi Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,396
-6.93%
|
$43,276
$31.54 P/Share
|
|
Feb 28
2025
|
Michael Bavaro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
30,996
-40.8%
|
$1,022,868
$33.26 P/Share
|
|
Feb 28
2025
|
Michael Bavaro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,739
+4.74%
|
$353,736
$24.39 P/Share
|
|
Feb 24
2025
|
Femi Adewunmi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,287
+33.79%
|
-
|
|
Feb 24
2025
|
John Charles Rademacher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,814
+9.05%
|
-
|
|
Feb 24
2025
|
Nicole Maggio Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,892
+23.38%
|
-
|
|
Feb 24
2025
|
Luke Whitworth Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,173
+15.32%
|
-
|
|
Feb 24
2025
|
Collin Smyser GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,964
+16.01%
|
-
|
|
Feb 24
2025
|
Michael H. Shapiro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,173
+9.09%
|
-
|
|
Feb 24
2025
|
Christopher L. Grashoff Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,404
+27.06%
|
-
|
|
Feb 24
2025
|
Michael Bavaro Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,599
+14.76%
|
-
|
|
Feb 23
2025
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-1.16%
|
$8,544
$32.0 P/Share
|
|
Feb 23
2025
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
785
-0.55%
|
$25,120
$32.0 P/Share
|
|
Feb 23
2025
|
Nicole Maggio Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-2.46%
|
$10,848
$32.0 P/Share
|
|
Feb 23
2025
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.52%
|
$8,544
$32.0 P/Share
|
|
Feb 23
2025
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,872
-0.86%
|
$187,904
$32.0 P/Share
|
|
Feb 23
2025
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,881
-0.67%
|
$60,192
$32.0 P/Share
|
|
Feb 22
2025
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-0.96%
|
$19,808
$32.0 P/Share
|
|
Feb 22
2025
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.97%
|
$14,784
$32.0 P/Share
|
|
Feb 22
2025
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,438
-1.0%
|
$46,016
$32.0 P/Share
|
|
Feb 22
2025
|
Nicole Maggio Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-2.53%
|
$11,424
$32.0 P/Share
|
|
Feb 22
2025
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
554
-1.08%
|
$17,728
$32.0 P/Share
|
|
Feb 22
2025
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,310
-0.77%
|
$169,920
$32.0 P/Share
|
|
Feb 22
2025
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,048
-0.72%
|
$65,536
$32.0 P/Share
|
|
Feb 21
2025
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83,524
-5.44%
|
$2,672,768
$32.0 P/Share
|
|
Feb 21
2025
|
John Charles Rademacher Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,087
+1.42%
|
-
|
|
Feb 20
2025
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-2.11%
|
$44,288
$32.39 P/Share
|
|
Feb 20
2025
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,677
-6.67%
|
$53,664
$32.39 P/Share
|
|
Feb 20
2025
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,923
-2.66%
|
$125,536
$32.39 P/Share
|
|
Feb 20
2025
|
Nicole Maggio Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
432
-2.97%
|
$13,824
$32.39 P/Share
|
|
Feb 20
2025
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,019
-1.94%
|
$32,608
$32.39 P/Share
|
|
Feb 20
2025
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,630
-1.38%
|
$340,160
$32.39 P/Share
|
|
Feb 20
2025
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,426
-1.87%
|
$173,632
$32.39 P/Share
|
|
Feb 18
2025
|
Collin Smyser GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
23,676
+26.53%
|
-
|
|
Feb 18
2025
|
John Charles Rademacher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157,830
+16.98%
|
-
|
|
Feb 18
2025
|
Michael Bavaro Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,219
+24.71%
|
-
|
|
Feb 18
2025
|
Luke Whitworth Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,893
+21.73%
|
-
|
|
Feb 18
2025
|
Michael H. Shapiro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,394
+16.52%
|
-
|